Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanistic study of zolbetuximab efficacy in CLDN18.2-positive gastric cancer with peritoneal dissemination
jRCT1030260471Recruiting
- Start
- Sep 2026
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Single-arm trial of zolbetuximab in gastric cancer (GC), sponsored by none. Started Sep 2026; status: recruiting.
02
Drugs
zolbetuximab
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on jRCT1030260471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1030260471.